The company Critical Diagnostics in collaboration with the Brigham and Women’s Hospital in Boston has developed a diagnosis kit called Presage that uses soluble IL1RL1 levels for diagnosis and prognosis of cardiovascular disease. The gene discussed is IL1RL1; the disease is cardiovascular disorder.